Screener

Net Income Loss

Name: Ionis Pharmaceuticals Net Income Loss by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Ionis Pharmaceuticals·Business Segments·1 segment·Rolls up to Net Income

Breakdown

Segment	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26	Q2 '26
Business Segments	-$146.94M	$123.55M	-$128.61M	-$229.39M	-$92.53M	-$114.65M
Total	-$146.94M	$123.55M	-$128.61M	-$229.39M	-$92.53M	-$114.65M

Business SegmentsView metric